Regencell Bioscience, Duolingo, Wynn Resorts, Diageo, and Mettler-Toledo International are the five Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are shares of companies that are based in the People’s Republic of China and trade on domestic exchanges such as the Shanghai and Shenzhen Stock Exchanges or abroad on markets like the Hong Kong Stock Exchange and as U.S.‐listed ADS/ADRs. These equities can include A-shares (renminbi-denominated), B-shares (foreign-currency-denominated), H-shares (HKSAR-listed), and various “red chip” or “P-chip” classes. Their performance offers investors exposure to the growth and risks of the Chinese economy and corporate sector. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.
Regencell Bioscience (RGC)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Regencell Bioscience stock traded up $12.63 during mid-day trading on Friday, reaching $22.99. The company had a trading volume of 18,796,157 shares, compared to its average volume of 2,462,882. Regencell Bioscience has a 52 week low of $0.08 and a 52 week high of $83.60.
Read Our Latest Research Report on RGC
Duolingo (DUOL)
Duolingo, Inc. operates as a mobile learning platform in the United States, the United Kingdom, and internationally. The company offers courses in 40 different languages, including Spanish, English, French, German, Italian, Portuguese, Japanese, and Chinese through its Duolingo app. It also provides a digital English language proficiency assessment exam.
DUOL traded down $1.61 during midday trading on Friday, hitting $395.39. The company had a trading volume of 552,232 shares, compared to its average volume of 724,368. Duolingo has a twelve month low of $145.05 and a twelve month high of $544.93. The firm's 50-day simple moving average is $477.28 and its 200-day simple moving average is $386.59. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.68 and a current ratio of 2.68. The company has a market capitalization of $17.97 billion, a PE ratio of 194.78, a P/E/G ratio of 3.00 and a beta of 0.89.
Read Our Latest Research Report on DUOL
Wynn Resorts (WYNN)
Wynn Resorts, Limited designs, develops, and operates integrated resorts. The company operates through four segments: Wynn Palace, Wynn Macau, Las Vegas Operations, and Encore Boston Harbor. The Wynn Palace segment operates private gaming salons and sky casinos; a luxury hotel tower with suites, and villas, including a health club, spa, salon, and pool; food and beverage outlets; retail space; meeting and convention space; and performance lake and floral art displays.
Wynn Resorts stock traded up $0.84 during midday trading on Friday, hitting $105.52. 1,407,270 shares of the stock were exchanged, compared to its average volume of 2,598,311. Wynn Resorts has a 52 week low of $65.25 and a 52 week high of $107.81. The company has a fifty day simple moving average of $90.03 and a two-hundred day simple moving average of $85.60. The stock has a market capitalization of $11.03 billion, a PE ratio of 29.31, a P/E/G ratio of 3.05 and a beta of 1.37.
Read Our Latest Research Report on WYNN
Diageo (DEO)
Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.
Shares of NYSE DEO traded down $0.51 during midday trading on Friday, reaching $104.48. The company's stock had a trading volume of 599,589 shares, compared to its average volume of 968,629. The stock has a market capitalization of $58.12 billion, a price-to-earnings ratio of 15.25 and a beta of 0.56. Diageo has a fifty-two week low of $99.26 and a fifty-two week high of $142.73. The stock has a 50 day simple moving average of $108.27 and a 200-day simple moving average of $111.71. The company has a current ratio of 1.60, a quick ratio of 0.67 and a debt-to-equity ratio of 1.62.
Read Our Latest Research Report on DEO
Mettler-Toledo International (MTD)
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Shares of Mettler-Toledo International stock traded up $3.43 during trading on Friday, reaching $1,209.08. The company's stock had a trading volume of 41,859 shares, compared to its average volume of 150,220. Mettler-Toledo International has a 52 week low of $946.69 and a 52 week high of $1,546.93. The business's 50-day moving average price is $1,150.84 and its 200-day moving average price is $1,196.01. The firm has a market cap of $25.12 billion, a PE ratio of 30.15, a P/E/G ratio of 3.72 and a beta of 1.37.
Read Our Latest Research Report on MTD
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Regencell Bioscience, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Regencell Bioscience wasn't on the list.
While Regencell Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
